Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Fampridine therapy increases walking speed of patients with MS in phase II/III trials

Oct. 29, 2010

BMPR-1A inhibition by RAP-661 increases bone mass and strength in mice

Oct. 28, 2010

Intravenous zanamivir administration is feasible in patients with severe flu

Oct. 28, 2010

Recent preclinical studies offer insight into mechanism of action of laquinimod

Oct. 28, 2010

New clinical data presented on anticancer agents GSK-2118436 and GSK-1120212

Oct. 28, 2010

Second dose enhances immunogenicity of MenACWY-TT flu vaccine in toddlers

Oct. 28, 2010

CD56(bright) NK cell count predicts response to daclizumab in relapsing-remitting MS

Oct. 28, 2010

Combination of BG-12 with IFN-beta 1a or glatiramer acetate is safe in healthy subjects

Oct. 27, 2010

BMS-690514 shows potential to treat non-small cell lung cancer

Oct. 27, 2010

GM-CSF adjuvant enhances efficacy of AIDS vaccine in rhesus macaques

Oct. 27, 2010

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...